Clinical Trials

Prostatic Neoplasms

NCT03197571 2025-02-21

QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy

Carcinoma, Transitional Cell

NCT02608359 2025-02-03

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Prostatic Neoplasms

NCT02905201 2025-02-03

TOGETHER

Prostatic Neoplasms

NCT06681870 2025-01-15

A Study of ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors

GenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT06390111 2024-11-22

ABLE-42

Phase 4 Withdrawn

Urinary Bladder Neoplasms

NCT03990194 2024-10-31

LEPTO

Prostatic Neoplasms

NCT06424717 2024-09-27

Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT05390645 2024-09-26

MANHATTAN

Metastatic Urothelial Cancer

NCT05338580 2024-04-15

Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors

DermatologicGenitourinaryThoracic

First-line Non-small-cell Lung Cancer

NCT02864784 2024-02-28

Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC

Castrate Resistant Prostate Cancer With Bone Metastasis

NCT03494803 2023-12-22

Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

Prostatic Neoplasms

NCT04555603 2023-11-21

Axitinib Therapy Management Study

Carcinoma, Renal Cell

NCT02232646 2023-11-14

A Study of BBI503 in Adult Patients With Advanced Urologic Malignancies

Carcinoma, Renal Cell, Carcinoma, Transitional Cell

NCT05454371 2023-11-13

URODETECT-WP2

Neoplasms, Prostatic Neoplasms

NCT06090318 2023-10-19

Milademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A Loss

DermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Renal Cell, Melanoma, Mesothelioma, Stomach Neoplasms

NCT05107427 2023-04-18

AVENU

Carcinoma, Transitional Cell

NCT05496192 2023-04-14

A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer

DermatologicGenitourinary

Carcinoma, Transitional Cell, Melanoma

NCT05259397 2023-03-08

PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01792882 2023-02-28

GBCPRT0008

BreastGastrointestinalGenitourinaryOther hematologic neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT05395260 2022-08-19

FL- 101 Study in Non-Metastatic MIBC

Phase EARLY_PHASE1 Withdrawn

Urinary Bladder Neoplasms

NCT05191017 2022-08-05

Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05104905 2022-05-11

RENACOL

GastrointestinalGenitourinary

Carcinoma, Renal Cell, Colonic Neoplasms

NCT05234606 2022-04-12

A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors

BreastGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Triple Negative Breast Neoplasms

NCT02061605 2022-04-06

LTW-KIDNEY

Carcinoma, Renal Cell

NCT03495479 2021-10-18

CAMPAS

Prostatic Neoplasms

NCT04680416 2021-08-25

Tissue Collection to ID TCRs From Renal Clear Cell Carcinoma Patients Responding to Immune Checkpoint Inhibitors

Carcinoma, Renal Cell

NCT04464967 2021-05-12

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT01566045 2021-04-28

MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer

Prostatic Neoplasms

NCT01401777 2021-04-27

Electromagnetic Tracking of Devices During Interventional Procedures - A Cryoablation Study

Carcinoma, Renal Cell

NCT00621413 2021-04-19

Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer

Neoplasms, Prostatic Neoplasms

NCT03589781 2021-03-30

Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate

Prostatic Neoplasms

NCT04609800 2020-12-21

CAROLINE

Carcinoma, Renal Cell

NCT04109092 2020-12-14

A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT04260360 2020-08-04

Trial of NanoDoce Intratumoral Injection in Renal Cell Carcinoma

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04006691 2020-05-07

Retreatment

Phase 3 Withdrawn